净利润增长80%只是起点,“分红模范生”药明康德后续还有现金分红大招?

同壁财经
Nov 13

要论资本市场“业绩硬、回报实”的标杆,药明康德(603259.SH/2359.HK)足以让股东安心。2025年前三季度,其归母净利润同比增长84.84%至120.76亿元,远超2024年全年水平。面对市场关于是否有进一步维护股东利益计划的关切,药明康德的回应掷地有声:上市七年以来累计回馈投资者200亿元,超同期净利润40%,并有信心、有底气,为相信公司优秀业务发展和管理执行能力的投资人持续创造更多...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10